Pfizer withdrew Oxbryta (voxelotor), a conditionally approved oral therapy for SCD, saying its benefits don't outweigh risks.

The women's sorority plans to donate $2 million by 2028 to St. Jude Children's Research Hospital, which offers care at no ...

Infections in sickle cell disease can be problematic and even fatal. Columnist Oluwatosin Adesoye, a patient and doctor, has ...

In honor of September's Sickle Cell Awareness Month, columnist Oluwatosin Adesoye shares her reasons for advocating for ...

Sickle cell carriers are at a slightly increased risk of blood clots, but the overall risk is still low, a study found.

A Nigerian hematologist will pursue a PhD in health policy at the University of Tennessee Health Science Center to help advance her work on programs for sickle cell disease (SCD) in her home country.

Adesoye Oluwatosin is a practicing physician, a passionate and award-winning sickle cell advocate, and educator. She’s the founder of Sickle Cell Celebs, an online community for people living with ...